查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856544

醫用射出成型市場：依產品類型、材料類型、應用、最終用戶和製程類型分類－2025-2032年全球預測

Medical Injection Molding Market by Product Type, Material Type, Application, End User, Process Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療射出成型市場規模將達到 389.8 億美元，複合年成長率為 6.12%。

關鍵市場統計數據
基準年 2024 242.2億美元
預計年份：2025年 257.4億美元
預測年份 2032 389.8億美元
複合年成長率 (%) 6.12%

全面介紹監管嚴格性、材料創新和精密製造的融合如何塑造醫療射出成型

醫療射出成型產業處於精密工程、嚴格法律規範和快速變化的臨床需求三者交匯的領域。材料、製程控制和設備設計的進步提高了對公差、生物相容性和滅菌合規性的要求，促使製造商追求設計與製造之間更緊密的整合。同時，全球供應鏈壓力和區域性監管差異也促使企業更加重視具有韌性的籌資策略和供應商資格認證通訊協定。

對加速技術現代化、材料演進以及正在改變產業製造策略的法規進行深入研究

近年來，醫療射出成型因技術創新、監管趨嚴以及臨床需求的不斷變化而發生了翻天覆地的變化。自動化和工業4.0技術已從試生產線推廣到生產車間，實現了更高的重複性、即時監控和整合品管。這些能力能夠滿足現代導管、植入式組件和藥物輸送裝置日益複雜的幾何形狀和更嚴格的尺寸公差要求。

分析關稅累積變更將如何促進採購多元化、本地製造業投資和供應商資格認證策略

對於在全球醫療設備零件價值鏈中運作的製造商和採購負責人而言，關稅政策和貿易措施已成為重要的考量。近期關稅環境對採購決策、資本投資和區域製造基地策略都產生了影響。企業已透過重新評估其供應商網路，並考慮近岸外包和在地化來應對這項挑戰，以降低跨境成本波動和前置作業時間不確定性的風險。

整合細分情報揭示了產品類型、材料科學、應用、最終用戶偏好和製程選擇如何相互關聯，從而驅動製造策略。

對市場區隔的深入理解對於使生產能力與產品和臨床需求相匹配至關重要。產品類型的區分非常重要，因為導管和診斷組件與藥物輸送和植入相比，其精確度和監管要求各不相同；手術器械則需要考慮一次性器械和可重複使用器械的可重複使用性和滅菌性。注射器和藥物輸送組件需要採用特殊的成型方法來維持流體公差和表面光潔度，這些都直接影響患者安全和給藥精度。

戰略區域分析概述了美洲、歐洲、中東和非洲以及亞太地區的動態變化將如何影響生產地點、供應商策略和監管方式。

區域動態在塑造製造策略和商業計劃方面持續發揮至關重要的作用。美洲地區擁有多元化的環境，包括先進的製造能力、集中的臨床需求以及強調合規性和透明度的法律規範。市場參與企業正將靠近主要醫療系統以及國內或近岸生產的物流優勢視為降低風險和縮短產品上市時間的策略槓桿。

一份詳盡的競爭分析報告，闡述了材料專業化、高效流程和持續供應如何決定差異化和供應商選擇動態。

醫療射出成型的競爭格局反映了專業細分市場企業與大型綜合契約製造的融合，後者提供從可製造設計到檢驗生產和供應的端到端服務。領先企業憑藉先進材料技術、微成型技術、多組件整合以及縮短客戶認證週期的有效監管途徑等優勢脫穎而出。有些公司擅長高度監管的植入組件，而有些公司則專注於注射器和一次性手術器械等大批量一次性零件。

為高階主管提供可操作的建議，以最佳化設計完整性、自動化投資、供應商多元化、跨職能協作和員工能力。

產業領導者應優先採取一系列切實可行的措施，以確保競爭優勢和營運韌性。首先，應儘早將產品設計和材料選擇與生產能力相匹配，確保從概念設計到驗證階段都貫徹生物相容性、耐滅菌性和生產流程等方面的可製造性設計原則。儘早進行配對可以減少返工，縮短開發週期，並提高規模化產量比率。

本文詳細描述了一種嚴謹的三角測量調查方法，該方法結合了主要相關人員訪談、技術文獻綜述和營運案例研究檢驗。

本調查方法採用三管齊下的方法，結合主要相關利益者訪談、技術文獻分析和營運案例研究檢驗，以獲得深入見解。主要訪談對象包括製造企業負責人、品質和法規專家以及產品開發團隊，旨在獲得關於材料選擇、工藝能力和供應鏈壓力的第一手觀點。這些訪談有助於更深入了解影響成型策略的商業限制因素和決策標準。

綜合各項結論，強調整合製造、監管合規和供應鏈彈性對於支援未來設備創新至關重要。

先進成型過程的融合、材料選擇的日益豐富以及監管要求的不斷提高，共同塑造了當前醫療射出成型的發展軌跡。那些積極擁抱流程自動化、投資於檢驗的品質體系，並將材料選擇與滅菌和臨床要求相匹配的企業，能夠更好地應對供應鏈的不確定性，並滿足不斷提升的性能要求。同時，靈活的採購和區域生產策略可以有效降低與貿易政策和物流相關的外部風險。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將持續過程監控與人工智慧主導的品質保證相結合，應用於射出成型醫療設備
  • 採用生物可吸收聚合物材料進行病患特異性植入射出成型應用
  • 開發用於導管組件整合生產的多組分射出成型工藝
  • 監管合規的複雜性推動了對數位化驗證成型設備和軟體的需求
  • 奈米技術塗層在醫用射出成型件的應用提高了生物相容性
  • 專注於採用醫用級再生聚合物化合物進行射出成型的永續製造

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的醫用射出射出成型市場

  • 導管
  • 診斷部件
  • 藥物輸送裝置
  • 植入
  • 手術器械
    • 免洗設備
    • 可重複使用的餐具
  • 注射器

9. 依材料類型分類的醫用射出射出成型市場

  • 彈性體
  • 矽酮
  • 熱塑性塑膠
    • 聚碳酸酯
    • 聚醚醚酮
    • 聚乙烯
    • 聚丙烯
    • 聚苯乙烯
  • 熱固性樹脂

第10章 按應用領域射出成型市場

  • 診斷
  • 藥物遞送
    • 自動注射器
    • 點滴筒
    • 預填充式注射器
  • 外科手術
  • 治療

第11章 依最終用戶分類的醫用射出射出成型市場

  • 門診醫療中心
  • 診斷實驗室
  • 家庭醫療保健
  • 醫院

第12章 依製程類型分類的醫用射出射出成型市場

  • 嵌件成型
  • 微型射出成型
  • 多組分模塑
  • 標準射出成型

第13章 區域性醫療射出射出成型市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫療注射射出成型市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫用射出射出成型市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Haitian International Holdings Limited
    • Arburg GmbH+Co KG
    • Sumitomo Heavy Industries, Ltd.
    • Milacron Holdings Corp.
    • Engel Holding GmbH
    • KraussMaffei Group GmbH
    • Wittmann Battenfeld GmbH
    • Shibaura Machine Co., Ltd.
    • Bole Machinery Co., Ltd.
    • Nissei Plastic Industrial Co., Ltd.
Product Code: MRR-742BD518128B

The Medical Injection Molding Market is projected to grow by USD 38.98 billion at a CAGR of 6.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 24.22 billion
Estimated Year [2025] USD 25.74 billion
Forecast Year [2032] USD 38.98 billion
CAGR (%) 6.12%

Comprehensive introduction framing the convergence of regulatory rigor, material innovation, and precision manufacturing reshaping medical injection molding

The medical injection molding sector stands at the intersection of precision engineering, stringent regulatory oversight, and rapidly evolving clinical requirements. Advances in materials, process controls, and device design have elevated expectations for tolerances, biocompatibility, and sterilization compatibility, driving manufacturers to pursue tighter integration between design and production. At the same time, global supply chain pressures and localized regulatory nuance have placed a premium on resilient sourcing strategies and supplier qualification protocols.

Consequently, executives are recalibrating priorities: investments in automation, quality management systems, and advanced materials selection are being evaluated against time-to-market and total cost of ownership considerations. Regulatory pathways continue to demand demonstrable process capability and traceability, prompting closer collaboration between regulatory, clinical, and manufacturing functions. Moreover, product complexity has grown as minimally invasive and drug delivery devices proliferate, requiring multi-material, multi-component molding solutions.

In this environment, leaders benefit from a structured view of how technical capability, compliance readiness, and supply-chain strategy coalesce to affect product commerciality. The following analysis synthesizes transformative shifts, policy impacts, segmentation intelligence, regional dynamics, competitive positioning, and practical recommendations to guide strategic decision-making in medical injection molding.

Insightful exploration of technological modernization, material evolution, and regulatory acceleration transforming manufacturing strategies in the industry

Over recent years the landscape of medical injection molding has undergone transformative shifts driven by technological innovation, regulatory tightening, and evolving clinical needs. Automation and Industry 4.0 technologies have migrated from pilot lines to production floors, enabling higher repeatability, real-time monitoring, and integrated quality controls. These capabilities support increasingly complex geometries and tighter dimensional tolerances required by modern catheters, implantable components, and drug delivery mechanisms.

Material science advancements have introduced a wider palette of biocompatible elastomers and high-performance thermoplastics, including polycarbonate and polyetheretherketone, which allow designers to reconcile mechanical performance with sterilization resilience. Concurrently, multi-component molding and micro injection molding have matured to accommodate drug delivery assemblies such as auto-injector housings and pre-filled syringe components, reducing assembly steps and exposure risks.

Regulatory expectations now emphasize process validation, traceability, and demonstrable control of particulate and extractables, accelerating adoption of automated inspection and data-driven quality assurance. Supply-chain resilience has moved to the forefront; nearshoring and diversified supplier networks are being considered to mitigate disruption and to comply with evolving trade and tariff policies. Taken together, these shifts are promoting a more integrated, quality-centric, and technologically enabled manufacturing model for medical devices.

Analytical assessment of how cumulative tariff developments drive sourcing diversification, localized production investments, and supplier qualification strategies

Tariff policies and trade measures have become a material consideration for manufacturers and procurement leaders operating in global value chains for medical device components. Recent tariff environments have influenced sourcing decisions, capital investments, and regional production footprint strategies. Firms have responded by reassessing supplier networks, considering nearshoring or regionalization to reduce exposure to cross-border cost volatility and lead-time uncertainty.

As a result, organizations are increasingly weighing the trade-offs between cost efficiency and supply continuity. Investment choices in automation and localized production can mitigate recurring tariff effects by lowering dependence on imported subassemblies and by enabling faster response to regulatory or clinical changes. Furthermore, longer qualification timelines for new suppliers have prompted companies to place higher value on established, audited partners with demonstrated compliance histories.

Procurement functions are therefore evolving from transactional buying toward strategic supplier relationship management, emphasizing contractual protections, dual sourcing strategies, and visibility into upstream material availability. In parallel, product design teams are re-evaluating material and process specifications to enable flexibility in sourcing. This cumulative effect of tariff-driven strategic realignment supports a more resilient and adaptable manufacturing posture across device lifecycles.

Integrated segmentation intelligence revealing how product typologies, material science, applications, end-user settings, and process choices interrelate to drive manufacturing strategy

A nuanced understanding of market segmentation is essential when aligning manufacturing capabilities to product and clinical needs. Product type distinctions matter because the precision and regulatory requirements for catheters and diagnostic components diverge from those for drug delivery devices and implants, while surgical instruments demand considerations around reusability and sterilization for both disposable and reusable instrument families. Syringes and drug delivery assemblies require specific molding approaches to maintain fluidic tolerances and surface finishes that directly affect patient safety and dosing accuracy.

Material selection further differentiates manufacturing pathways. Elastomers and medical-grade silicone address flexibility and sealing requirements, whereas thermoplastics deliver structural integrity; within thermoplastics, grades such as polycarbonate and polyetheretherketone provide high-temperature and chemical resistance, while polyethylene, polypropylene, and polystyrene offer processability and cost-effectiveness depending on application demands. Thermosets remain relevant where dimensional stability and thermal performance under sterilization are critical.

Application-driven priorities influence design and process choices as well. Diagnostic devices prioritize optical clarity and dimensional precision, drug delivery systems such as auto-injectors, infusion cartridges, and pre-filled syringes emphasize dosing reliability and patient usability, surgical applications require sterilization robustness, and therapeutic devices focus on long-term biocompatibility. End-user settings shape operational requirements, with ambulatory care centers and home healthcare demanding ease of use and supply-chain responsiveness, diagnostic laboratories requiring throughput and repeatability, and hospitals prioritizing sterility assurance and device lifecycle support.

Process type selection-whether insert molding, micro injection molding, multi-component molding, or standard injection molding-connects these product, material, and application imperatives to production capability. Micro molding enables the manufacture of intricate, small-form components for minimally invasive devices, insert molding allows integration of metal or pre-assembled inserts for complex assemblies, and multi-component molding reduces downstream assembly while ensuring material interfaces meet performance expectations. Understanding these interdependencies is critical for aligning manufacturing strategy with clinical and commercial objectives.

Strategic regional analysis outlining how the Americas, Europe Middle East & Africa, and Asia-Pacific dynamics inform production location, supplier strategy, and regulatory approach

Regional dynamics continue to play a defining role in shaping manufacturing strategy and commercial planning. The Americas present a mixed environment of advanced manufacturing capability, concentrated clinical demand, and regulatory oversight that emphasizes compliance and transparency. Market participants consider proximity to major healthcare systems and the logistical advantages of domestic or nearshore production as strategic levers for reducing risk and improving time to market.

The Europe, Middle East & Africa region combines sophisticated regulatory frameworks with variable market access considerations across countries, necessitating adaptive regulatory strategies and localized clinical engagement. Manufacturers operating in this broader region must balance harmonized technical standards with country-specific requirements, and many leverage regional centers of excellence for specialized production and testing to meet complex clinical and regulatory needs.

Asia-Pacific continues to be a focal point for capacity expansion, rapid manufacturing scale-up, and access to specialized material suppliers. The region's diverse industrial base supports both low-cost production and high-precision machining, making it attractive for companies seeking to optimize cost structures while accessing advanced materials and component suppliers. However, navigating regional regulatory variance, intellectual property considerations, and quality assurance expectations remains essential for firms seeking sustainable operations and long-term market penetration.

In each region, strategic decisions around facility location, supplier partnerships, and regulatory engagement are informed by local talent pools, logistical networks, and the evolving landscape of trade policies and clinical demand.

In-depth competitive view describing how specialization in materials, validated processes, and supply continuity determine differentiation and supplier selection dynamics

Competitive dynamics in medical injection molding reflect a blend of specialized niche players and larger integrated contract manufacturers that offer end-to-end services from design for manufacturability to validated production and supply. Leading firms differentiate through capabilities such as advanced material expertise, micro molding proficiency, multi-component integration, and validated regulatory pathways that shorten qualification cycles for customers. Some operators excel at highly regulated implantable components, while others focus on high-volume disposable components like syringes and single-use surgical instruments.

Strategic partnerships and vertical integration continue to shape the competitive landscape. Companies that invest in process automation, inline inspection, and data-driven quality management systems establish higher barriers to entry, particularly for complex applications requiring traceability and rigorous process control. Meanwhile, firms offering modular, scalable manufacturing solutions can attract customers seeking faster commercialization timelines and flexible capacity.

Supply reliability, documented quality systems, and experience with sterilization validation are recurrent differentiators when purchasers evaluate potential manufacturing partners. Additionally, the ability to support design optimization for manufacturability, to provide rapid prototyping into validated pilot production, and to assure continuity of supply under changing trade conditions are increasingly central to vendor selection criteria. Competitive positioning therefore rests on a combination of technical depth, regulatory competence, and supply-chain resilience.

Actionable recommendations for executives to optimize design alignment, automation investment, supplier diversification, cross-functional collaboration, and workforce capability

Industry leaders should prioritize a set of pragmatic actions to secure competitive advantage and operational resilience. First, align product design and material selection early with manufacturing capabilities, ensuring that biocompatibility, sterilization resilience, and design-for-manufacture principles are embedded from concept through validation. Early alignment reduces rework, shortens development cycles, and improves yield during scale-up.

Second, invest in process automation and real-time quality analytics to reduce variability and to meet growing regulatory expectations for traceability and control. These investments pay dividends by lowering defect rates and by enabling faster, data-supported responses to audits and post-market inquiries. Third, develop flexible sourcing strategies that incorporate dual sourcing, qualified regional suppliers, and contingency planning to mitigate trade policy and logistics disruptions. Such strategies should be complemented by contractual protections and periodic supplier performance reviews.

Fourth, foster cross-functional collaboration between R&D, regulatory, procurement, and operations to expedite supplier qualification and to ensure that product specifications remain manufacturable under multiple sourcing scenarios. Finally, prioritize workforce development and retention programs that cultivate mold design, material science, and process control expertise, because human capability remains critical to translating advanced technologies into reliable production outcomes. By executing these actions, organizations can balance innovation with regulatory compliance and supply resilience.

Detailed description of a rigorous triangulated research methodology combining primary stakeholder interviews, technical literature review, and operational case study validation

The research synthesis derives its insights from a triangulated methodology combining primary stakeholder engagement, technical document analysis, and verification against operational case studies. Primary engagements included structured interviews with manufacturing leaders, quality and regulatory professionals, and product development teams to capture firsthand perspectives on materials selection, process capability, and supply-chain pressures. These dialogues informed an understanding of the operational constraints and decision criteria that shape molding strategy.

Secondary analysis comprised a review of publicly available technical literature, regulatory guidance, and industry whitepapers to contextualize process trends, material innovations, and quality expectations. In parallel, anonymized operational case studies and factory acceptance reports were examined to verify trends in process automation, inspection regimes, and product complexity. Cross-validation steps were applied to reconcile disparate inputs and to ensure that findings reflected consistent themes rather than isolated anecdotes.

Throughout the methodology, emphasis was placed on process traceability, reproducibility of observations, and alignment with regulatory best practices. Where appropriate, sensitivity analyses of strategic choices were used to present alternative implementation pathways for manufacturers of varying scale and technical capability.

Concluding synthesis emphasizing the imperative for integrated manufacturing, regulatory readiness, and supply resilience to support future device innovation

The convergence of advanced molding processes, expanding material options, and heightened regulatory expectations defines the current trajectory for medical injection molding. Organizations that embrace process automation, invest in validated quality systems, and align material choices with sterilization and clinical requirements will be better positioned to navigate supply-chain uncertainty and to meet escalating performance demands. At the same time, flexible sourcing and regional production strategies can mitigate external risks related to trade policy and logistics.

For product teams, the imperative is clear: design for manufacturability and early engagement with qualified suppliers reduce time to clinical readiness and improve production readiness. Procurement and operations should prioritize supplier qualification, cross-validated risk mitigation plans, and investments that support traceability and rapid regulatory response. Collectively, these actions underpin a manufacturing model that is resilient, compliant, and capable of supporting next-generation medical devices.

As the sector continues to evolve, leaders must balance near-term tactical responses to trade and supply-chain dynamics with strategic investments in capability that drive long-term differentiation. In doing so, companies will be able to translate current challenges into opportunities for operational excellence and clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of continuous process monitoring and AI-driven quality assurance for injection molded medical devices
  • 5.2. Adoption of bioresorbable polymer materials for patient-specific implant injection molding applications
  • 5.3. Development of multi-component injection molding processes for integrated catheter assembly production
  • 5.4. Increasing regulatory compliance complexity driving demand for digitally validated molding equipment and software
  • 5.5. Rise of nanotechnology-enabled coatings in injection molded medical components to enhance biocompatibility
  • 5.6. Focus on sustainable manufacturing through recycled medical-grade polymer compounds in injection molding

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Injection Molding Market, by Product Type

  • 8.1. Catheters
  • 8.2. Diagnostic Components
  • 8.3. Drug Delivery Devices
  • 8.4. Implants
  • 8.5. Surgical Instruments
    • 8.5.1. Disposable Instruments
    • 8.5.2. Reusable Instruments
  • 8.6. Syringes

9. Medical Injection Molding Market, by Material Type

  • 9.1. Elastomers
  • 9.2. Silicone
  • 9.3. Thermoplastics
    • 9.3.1. Polycarbonate
    • 9.3.2. Polyetheretherketone
    • 9.3.3. Polyethylene
    • 9.3.4. Polypropylene
    • 9.3.5. Polystyrene
  • 9.4. Thermosets

10. Medical Injection Molding Market, by Application

  • 10.1. Diagnostics
  • 10.2. Drug Delivery
    • 10.2.1. Auto-Injectors
    • 10.2.2. Infusion Cartridges
    • 10.2.3. Pre-Filled Syringes
  • 10.3. Surgical
  • 10.4. Therapeutics

11. Medical Injection Molding Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Diagnostic Laboratories
  • 11.3. Home Healthcare
  • 11.4. Hospitals

12. Medical Injection Molding Market, by Process Type

  • 12.1. Insert Molding
  • 12.2. Micro Injection Molding
  • 12.3. Multi Component Molding
  • 12.4. Standard Injection Molding

13. Medical Injection Molding Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Injection Molding Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Injection Molding Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Haitian International Holdings Limited
    • 16.3.2. Arburg GmbH + Co KG
    • 16.3.3. Sumitomo Heavy Industries, Ltd.
    • 16.3.4. Milacron Holdings Corp.
    • 16.3.5. Engel Holding GmbH
    • 16.3.6. KraussMaffei Group GmbH
    • 16.3.7. Wittmann Battenfeld GmbH
    • 16.3.8. Shibaura Machine Co., Ltd.
    • 16.3.9. Bole Machinery Co., Ltd.
    • 16.3.10. Nissei Plastic Industrial Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MEDICAL INJECTION MOLDING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MEDICAL INJECTION MOLDING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL INJECTION MOLDING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DISPOSABLE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REUSABLE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY ELASTOMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHERETHERKETONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY POLYSTYRENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOSETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INFUSION CARTRIDGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY INSERT MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MICRO INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY MULTI COMPONENT MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY STANDARD INJECTION MOLDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL INJECTION MOLDING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDING MARKET SIZE, BY PROCESS TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY SURGICAL INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE MEDICAL INJECTION MOLDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)

TA